Transcriptional activation of insulin-like growth factor-binding protein-4 by 17β-estradiol in MCF-7 cells: Role of estrogen receptor-sp1 complexes

Endocrinology

Volumn 140, Issue 6, 1999, Pages 2501-2508

  Qin, Chunhua ^a   Singh, Pomila ^b   Safe, Stephen ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR; SOMATOMEDIN BINDING PROTEIN 4; TRANSCRIPTION FACTOR SP1;

ARTICLE; CELL STRAIN MCF 7; DNA BINDING; GENE ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN SECRETION; TRANSCRIPTION REGULATION;

EID: 0033278993     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.140.6.6751     Document Type: Article

References (58)

1. Insulin-like growth factors and their binding proteins: Biological actions
2. IGF binding proteins and their functions
3. Insulin-like growth factors and cancer
4. Binding proteins for the insulin-like growth factors: Structure, regulation and function
5. Insulin-like growth factor binding proteins: Gene structure and expression
6. Insulin-like growth factor-binding proteins
7. How many insulin-like growth factor binding proteins?
8. A follistatin-like gene, mac25, may act as a growth suppressor of osteosarcoma cells
9. Identification of a family of low-affinity insulin-like growth factor binding proteins (IGFBPs): Characterization of connective tissue growth factor as a member of the IGFBP superfamily
10. Enhanced expression of an insulin growth factor-like binding protein (mac25) in senescent human mammary epithelial cells and induced expression with retinoic acid
11. Generation and characterization of an IGFBP-7 antibody: Identification of 31kD IGFBP-7 in human biological fluids and Hs578T human breast cancer conditioned media
12. Insulin-like growth factor binding protein secretion by breast carcinoma cell lines: Correlation with estrogen receptor status
13. Identification of insulin-like growth factor binding proteins in breast cancer cells
14. The insulin-like growth factor binding protein BP-25 is expressed by human breast cancer cells
15. Insulin-like growth factor binding proteins in human breast cancer cells: Relationship to hIGFBP-2 and hIGFBP-3
16. Regulation of insulin-like growth factor-binding protein (IGFBP) expression by breast cancer cells: Use of IGFBP-1 as an inhibitor of insulin-like growth factor action
17. IGFBP-3 gene expression and estrogen receptor status in human breast carcinoma
18. Identification of the insulin-like growth factor binding proteins 5 and 6 (IGFBP-5 and 6) in human breast cancer cells
19. Insulin-like growth factor binding proteins in human breast cancer tissue
20. The insulin-like growth factor binding proteins (IGFBPs) in human breast cancer
21. Insulin-like growth factor binding protein (IGFBP)-3 levels in conditioned media of Hs578T human breast cancer cells are post-transcriptionally regulated
22. Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cells
23. Detection of insulin-like growth factor binding proteins (IGFBPs) by ligand blotting in breast cancer tissues
24. Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition
25. Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor β2-induced growth inhibition in human breast cancer cells
26. Insulin-like growth factor binding protein 3 (IGF-BP3) inhibits estrogen-stimulated breast cancer cell proliferation
27. Estradiol and antiestrogens regulate a growth inhibitory insulin-like growth factor binding protein 3 autocrine loop in human breast cancer cells
28. Transforming growth factor-β-induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein-3 action
29. Insulin-like growth factor binding protein-3 induces apoptosis in MCF7 breast cancer cells
30. Insulin-like growth factor-binding protein (IGFBP-3) predisposes breast cancer cells to programmed cell death in a non-IGF-dependent manner
31. Insulin-like growth factor-binding protein-3 production by MCF-7 breast cancer cells: Stimulation by retinoic acid and cyclic adenosine monophosphate and differential effects of estradiol
32. The type V transforming growth factor β receptor is the putative insulin-like growth factor-binding protein 3 receptor
33. Expression of insulin-like growth factor binding proteins in human breast cancer correlates with estrogen receptor status
34. Retinoic acid and estrogen modulation of insulin-like growth factor binding protein-4 gene expression and the estrogen receptor status of human breast carcinoma cells
35. Estrogen and progesterone regulate secretion of insulin-like growth factor binding proteins by human breast cancer cells
36. Estrogen and antiestrogen modulation of MCF7 human breast cancer cell proliferation is associated with specific alterations in accumulation of insulin-like growth factor-binding proteins in conditioned media
37. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on insulin-like growth factor binding protein 4 in MCF-7 and T47D human breast cancer cells
38. Cloning of the functional promoter for human insulin-like growth factor binding protein-4 gene: Endogenous regulation
39. Structural and functional analysis of the 5′-flanking region of the human insulin-like growth factor binding protein (IGFBP)-4 gene
40. Functional synergy between the transcription factor Sp1 and the estrogen receptor
41. Estrogen-induced c-fos protooncogene expression in MCF-7 human breast cancer cells: Role of estrogen receptor Sp1 complex formation
42. Functional and physical interactions between the estrogen receptor-Sp1 and the nuclear aryl hydrocarbon receptor complexes
43. Estrogen-induced retinoic acid receptor α1 gene expression: Role of estrogen receptor-Sp1 complex
44. Estrogen induces adenosine deaminase gene expression in MCF-7 human breast cancer cells: Role of estrogen receptor-Sp1 interactions
45. Episomal expression of sense and antisense insulin-like growth factor (IGF)-binding protein-4 complementary DNA alters the mitogenic response of a human colon cancer cell line (HT-29) by mechanisms that are independent of and dependent upon IGF-I
46. Expression of IGF-II and IGF-binding proteins by colon cancer cells in relation to growth response to IGFs
47. Insulin-like growth factors and binding proteins in colon cancer
48. Studies on the mechanisms by which insulin-like growth factor (IGF) binding protein-4 (IGFBP-4) and IGFBP-5 modulate IGF actions in bone cells
49. Proliferation and differentiation of a human colon cancer cell line (CaCo2) is associated with significant changes in the expression and secretion of insulin-like growth factor (IGF) IGF- II and IGF binding protein-4: Role of IGF-II
50. Tamoxifen activation of the estrogen receptor/AP-1 pathway: Potential origin for the cell-specific estrogen-like effects of antiestrogens
51. HTLV-1 Tax protein stimulation of DNA binding of bZIP proteins by enhancing dimerization
52. Cooperation by sterol regulatory element-binding protein and Sp1 in sterol regulation of low density lipoprotein receptor gene
53. CDK-independent activation of estrogen receptor by cydin D1
54. Mechanism of estrogen activation of c-myc oncogene expression
55. Delineation of sites mediating estrogen regulation of the rat creatine kinase B gene
56. Estrogen receptor-Sp1 complexes mediate estrogen-induced cathepsin D gene expression in MCF-7 human breast cancer cells
57. Role of estrogen receptor/ Sp1 complexes in estrogen-induced heat shock protein 27 gene expression
58. WAF1 cyclin-dependent kinase inhibitor gene through Sp1 and CBP/p300